Camlin Fine Sciences Limited
NSE: CAMLINFINE · Specialty Chemicals
Snapshot
Unlock Camlin Fine Sciences Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Camlin Fine Sciences Limited is a global provider of specialty chemicals, shelf-life extension solutions, and aroma ingredients. The company manufactures a diverse range of additives, antioxidants, and performance chemicals serving industries such as food and beverage, animal nutrition, and pharmaceuticals.
Business Model
The company generates revenue through the research, development, and large-scale manufacturing of chemical ingredients sold to global industrial clients. It leverages a vertically integrated production process for performance chemicals and proprietary brands like Xtendra and NaSure to capture value across the supply chain.
Growth Outlook
Growth is driven by the increasing global demand for shelf-life extension solutions and natural antioxidants in the food and pet food sectors. Expansion into nutraceuticals and downstream fine chemicals provides additional avenues for market penetration.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical feedstocks can significantly impact operating margins.
- Regulatory Compliance. The company faces stringent global safety and environmental regulations regarding chemical manufacturing and food additives.
- Foreign Exchange Risk. As a significant exporter, the company is exposed to currency fluctuations that may affect international competitiveness and profitability.
- Competitive Intensity. The specialty chemicals market is highly competitive, requiring continuous R&D investment to maintain product differentiation.
Start your research today
Unlock AI insights, financials, peers and live data on Camlin Fine Sciences Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,862 Cr
TTM · consolidated
NET PROFIT
₹0.61 Cr
TTM · consolidated
EPS
₹0.27
TTM · consolidated
RETURN ON EQUITY
0.1%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
0.5%
TTM · consolidated
P/E
382.0x
Q1 FY27 · consolidated
EV/EBITDA
21.4x
Q1 FY27 · consolidated
EBITDA MARGIN
6.4%
TTM · consolidated
NET PROFIT MARGIN
-6.5%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.6x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Camlin Fine Sciences LimitedCAMLINFINE | ₹1,981 Cr | 381.96 | 21.41 | 8.4% | 6.4% | 0.1% | 0.5% | -51.1% |
S H Kelkar & Co.SHK | ₹2,088 Cr | 23.46 | 10.77 | 9.7% | 10.9% | 6.8% | 12.3% | -43.4% |
PaushakPAUSHAKLTD | ₹1,937 Cr | 10.54 | 27.62 | 3.6% | 33.3% | 8.3% | 9.5% | -87.1% |
Titan BiotechTITANBIO | ₹1,793 Cr | 14.64 | 40.79 | 34.5% | 21.3% | 18.6% | 23.7% | -36.6% |
Oriental Aromatics LimitedOAL | ₹1,750 Cr | 329.05 | 26.71 | 13.5% | 7.5% | 0.8% | 6.4% | +51.4% |
IndokemINDOKEM | ₹1,745 Cr | — | — | — | 2.8% | — | — | +33.0% |
As of Q1 FY27
Financials
Camlin Fine Sciences Limited
NSE: CAMLINFINE · Specialty Chemicals
Snapshot
Unlock Camlin Fine Sciences Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Camlin Fine Sciences Limited is a global provider of specialty chemicals, shelf-life extension solutions, and aroma ingredients. The company manufactures a diverse range of additives, antioxidants, and performance chemicals serving industries such as food and beverage, animal nutrition, and pharmaceuticals.
Business Model
The company generates revenue through the research, development, and large-scale manufacturing of chemical ingredients sold to global industrial clients. It leverages a vertically integrated production process for performance chemicals and proprietary brands like Xtendra and NaSure to capture value across the supply chain.
Growth Outlook
Growth is driven by the increasing global demand for shelf-life extension solutions and natural antioxidants in the food and pet food sectors. Expansion into nutraceuticals and downstream fine chemicals provides additional avenues for market penetration.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical feedstocks can significantly impact operating margins.
- Regulatory Compliance. The company faces stringent global safety and environmental regulations regarding chemical manufacturing and food additives.
- Foreign Exchange Risk. As a significant exporter, the company is exposed to currency fluctuations that may affect international competitiveness and profitability.
- Competitive Intensity. The specialty chemicals market is highly competitive, requiring continuous R&D investment to maintain product differentiation.
Start your research today
Unlock AI insights, financials, peers and live data on Camlin Fine Sciences Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,862 Cr
TTM · consolidated
NET PROFIT
₹0.61 Cr
TTM · consolidated
EPS
₹0.27
TTM · consolidated
RETURN ON EQUITY
0.1%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
0.5%
TTM · consolidated
P/E
382.0x
Q1 FY27 · consolidated
EV/EBITDA
21.4x
Q1 FY27 · consolidated
EBITDA MARGIN
6.4%
TTM · consolidated
NET PROFIT MARGIN
-6.5%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.6x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27